Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 16714-825

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 16714-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

This appears to be a table showing the results of a study comparing the effectiveness of Propafenone SR at different dosages to a placebo in patients. The table shows the number of patients at risk and the occurrence of events over various time points. The "p" values indicate the statistical significance of the results. There is a note indicating that patient closeout started on day 273, and there was a decline in the Kaplan-Meier curves on day 291 due to an event in one patient.*

FDA Label Image

Propafenone-225mg-60-capsules.jpg (Propafenone 225mg 60 Capsules)

Each capsule of this medicine contains 225mg of propafenone hydrochloride. The usual dosage instructions are provided in the prescribing information that comes with the medicine. The capsules should be stored within a temperature range of 20°C to 25°C, with slight excursions allowed according to the USP-controlled room temperature guidelines. The medicine should be kept in a tight container. If the seal over the bottle opening is broken or missing, the medicine should not be consumed. The medicine has been manufactured for Northstar Rx LLC Holdings UC by Glenmark Pharmaceuticals Ltd. in India.*

FDA Label Image

Propafenone-325mg-60-capsules.jpg (Propafenone 325mg 60 Capsules)

Each capsule of this medication contains 325 mg of propafenone hydrochloride, USP. It is an extended-release capsule and should be stored at a controlled room temperature of 20 to 25°C, with excursions permitted to 16 to 30°C. The medication should be dispensed in a tight container as per USP (United States Pharmacopeia) guidelines. The usual dosage should be determined based on accompanying prescribing information. This product is manufactured for Northstar Rx LLC and manufactured by Glenmark Pharmaceuticals Ltd. It comes in a bottle containing 60 capsules and should not be accepted if the seal over the bottle opening is broken or missing.*

FDA Label Image

Propafenone-425mg-60-capsules.jpg (Propafenone 425mg 60 Capsules)

This is a medication containing 425 mg of extended-release propafenone hydrochloride, dispensed in a tightly sealed container with dosage instructions available in the prescribing information. The medication is manufactured by Glenmark Pharmaceuticals Ltd. and distributed by Northstar Rx LLC in Memphis, TN. The medication should be stored at a temperature between 15 to 30°C and 59 to 86°F. The National Drug Code (NDC) for this medication is 16714-827-01.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.